Beyond BCMA: newer immune targets in myeloma
Sign Up to like & getrecommendations! Published in 2024 at "Blood Advances"
DOI: 10.1182/bloodadvances.2023010856
Abstract: Abstract The identification and targeting of B-cell maturation antigen (BCMA) through immunotherapeutic strategies such as antibody-drug conjugates, chimeric antigen receptor T cells, and T-cell engagers have revolutionized the care of patients with multiple myeloma (MM).… read more here.
Keywords: bcma; beyond bcma; immune targets; newer immune ... See more keywords